VA
IDXX icon

Vident Advisory’s Idexx Laboratories IDXX Stock Holding History

Vident Advisory’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6M Buy
10,677
+7,466
+233% +$4.79M 0.05% 307
2025
Q4 		$2.17M Sell
3,211
-5,470
-63% -$3.73M 0.02% 551
2025
Q3 		$5.55M Buy
8,681
+5,784
+200% +$3.51M 0.05% 278
2025
Q2 		$1.55M Buy
2,897
+152
+6% +$72.7K 0.02% 592
2025
Q1 		$1.15M Buy
2,745
+716
+35% +$311K 0.02% 671
2024
Q4 		$839K Sell
2,029
-820
-29% -$360K 0.01% 705
2024
Q3 		$1.44M Sell
2,849
-7,324
-72% -$3.56M 0.04% 505
2024
Q2 		$4.96M Buy
10,173
+402
+4% +$202K 0.14% 143
2024
Q1 		$5.28M Buy
9,771
+370
+4% +$202K 0.11% 207
2023
Q4 		$5.22M Buy
9,401
+444
+5% +$208K 0.13% 178
2023
Q3 		$3.92M Buy
+8,957
New +$4.47M 0.12% 177

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vident Advisory's IDXX Position: Q1 2026 in Review

Vident Advisory increased its Idexx Laboratories (IDXX) stake by 233% in Q1 2026, buying an estimated $4.79M and bringing the position to 10,677 shares worth $6M. The position accounts for 0.05% of the portfolio, ranked #307.

Vident Advisory first reported a position in IDXX in Q3 2023 and has held it in 11 quarters since. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Vident Advisory held 10,677 shares of Idexx Laboratories worth $6M as of Q1 2026.
  • Vident Advisory bought 7,466 Idexx Laboratories shares in Q1 2026, an estimated $4.79M.
  • Idexx Laboratories made up 0.05% of Vident Advisory's portfolio in Q1 2026, its #307 holding.
  • Vident Advisory first reported a position in Idexx Laboratories in Q3 2023 and has held it in 11 quarters since.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.